Is combination therapy for resistant vitreous seeds really essential? - reply.
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Fariba
F
Ghassemi
Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania.
Carol L
CL
Shields
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Alireza
A
Khodabande
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D009366:Neoplasm Seeding; D019572:Retinal Neoplasms / Q000188:drug therapy*; D019772:Topotecan / Q000008:administration & dosage*; D014822:Vitreous Body / Q000473:pathology*
D019772:Topotecan; D008558:Melphalan